New Investigator Initiated Research Data Demonstrate Efficacy and Safety of the Bridge to Life's VitaSmart™ Hypothermic Oxygenated Perfusion (HOPE) System in Multiple Organ Transplants
Bridge to Life presented new clinical data at the American Transplant Congress demonstrating the efficacy of its VitaSmart HOPE system for uterus and small intestine transplants. The study suggests that hypothermic oxygenated perfusion could significantly improve organ preservation outcomes beyond its current FDA-cleared use for livers.
Why it matters
Advancements in organ perfusion technology could drastically increase the viability of donor organs, potentially reducing wait times and improving success rates for complex transplant surgeries.
Studies in human uterus and small intestine transplants, including head-to-head comparison with normothermic oxygenated perfusion, presented at 2026 Annual Meeting of the American Transplant Congress (ATC) in Boston
The article is a straightforward summary of a corporate press release regarding clinical research findings.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in